Inflammation in Patients with Schizophrenia: The Therapeutic Benefits of Risperidone Plus Add-On Dextromethorphan

Cortical Volume, Surface Area, and Thickness in Schizophrenia and Bipolar Disorder

(2012) Lars M. Rimol et al.   BIOLOGICAL PSYCHIATRY

Systematic meta-review and quality assessment of the structural brain alterations in schizophrenia

(2012) Alana M. Shepherd et al.   NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS

Novel CSF biomarkers for Alzheimer’s disease and mild cognitive impairment

(2010) William T. Hu et al.   ACTA NEUROPATHOLOGICA

Tyrosine hydroxylase, interleukin-1β and tumor necrosis factor-α are overexpressed in peripheral blood mononuclear cells from schizophrenia patients as determined by semi-quantitative analysis

(2010) Liang Liu et al.   PSYCHIATRY RESEARCH

Similar immune profile in bipolar disorder and schizophrenia: selective increase in soluble tumor necrosis factor receptor I and von Willebrand factor

(2009) Sigrun Hope et al.   BIPOLAR DISORDERS

A New Aspect of the TrkB Signaling Pathway in Neural Plasticity

(2009) K. Ohira et al.   Current Neuropharmacology

Activation of brain interleukin-1β in schizophrenia

(2009) J Söderlund et al.   MOLECULAR PSYCHIATRY

Increased Plasma Brain-Derived Neurotropic Factor, Not Nerve Growth Factor-Beta, in Schizophrenia Patients with Better Response to Risperidone Treatment

(2009) Bun-Hee Lee et al.   NEUROPSYCHOBIOLOGY

The Interaction of Nuclear Factor-Kappa B and Cytokines Is Associated with Schizophrenia

(2008) Xue-Qin Song et al.   BIOLOGICAL PSYCHIATRY

Atypical antipsychotics suppress production of proinflammatory cytokines and up-regulate interleukin-10 in lipopolysaccharide-treated mice

(2008) Haruhiko Sugino et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

Changes in plasma levels of BDNF and NGF reveal a gender-selective vulnerability to early adversity in rhesus macaques

(2008) Francesca Cirulli et al.   PSYCHONEUROENDOCRINOLOGY

Reduced serum BDNF levels in patients with chronic schizophrenic disorder in relapse, who were treated with typical or atypical antipsychotics

(2008) Emmanouil Rizos et al.   WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY